Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood, and Sleep Technologies with Small Commercial Markets (R44)

Funding Opportunity Number: RFA-HL-17-012
Opportunity Category: Discretionary
Funding Instrument Type: Grant
Category of Funding Activity: Health
CFDA Number: 93.233
Eligible Applicants Small businesses
Agency Name: HHS-NIH11
Closing Date: Jun 20, 2018
Award Ceiling: $3,000,000
Expected Number of Awards:
Creation Date: Apr 18, 2016
Funding Opportunity Description: The purpose of the NHLBI SBIR Phase IIB Small Market Award is to provide support to Phase II SBIR or STTR awardees developing NHLBI mission-related technologies that address a rare disease or young pediatric populations. The goal of this FOA is for these technologies to be further validated so that development can continue with private funding after NHLBI support ends. Applicants must submit a Commercialization Plan that includes details on any independent third-party funding that has already been secured or is anticipated during the project period. It is expected that the level of this independent third-party funding will be equal to or greater than one-third of the NHLBI funds being requested throughout the project period. Projects proposed in response to this FOA must require eventual Federal regulatory approval/clearance, and may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate, but are not required.



Please enter your comment!
Please enter your name here